1. Home
  2. QUIK vs RCEL Comparison

QUIK vs RCEL Comparison

Compare QUIK & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$10.80

Market Cap

139.5M

Sector

Technology

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.54

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
RCEL
Founded
1988
N/A
Country
United States
United States
Employees
N/A
226
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.5M
132.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QUIK
RCEL
Price
$10.80
$4.54
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$11.00
$7.88
AVG Volume (30 Days)
186.6K
177.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
$17.17
Revenue Next Year
$16.04
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$3.22
52 Week High
$10.37
$10.28

Technical Indicators

Market Signals
Indicator
QUIK
RCEL
Relative Strength Index (RSI) 70.87 56.23
Support Level $5.96 $4.24
Resistance Level N/A $4.57
Average True Range (ATR) 0.60 0.23
MACD 0.05 0.04
Stochastic Oscillator 97.98 86.08

Price Performance

Historical Comparison
QUIK
RCEL

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: